Suchergebnisse - "Chan, Tom S."

PubPharm (67)

1

Comparison of commonly used and new methods to determine small molecule non-specific binding to human liver microsomes

enthalten in: Journal of pharmaceutical sciences | 2024

von Wang, T. | Whitcher-Johnstone, A. | Scaringella, Y. | +4

2

A novel system to determine activity of individual uridine 5'-diphospho-glucuronosyltransferase (UGT) isoforms : recombinant UGT-beads

enthalten in: The Journal of biological chemistry | 2024

von Wang, T. | Taub, M. | Chan, T.

3

Considerations from an International Regulatory and Pharmaceutical Industry (IQ MPS Affiliate) Workshop on the Standardization of Complex In Vitro Models in Drug Development

enthalten in: Advanced biology | 2023

von Tomlinson, L. | Ramsden, D. | Leite, S. | +28

4

Characterization of Divergent Metabolic Pathways in Elucidating an Unexpected, Slow-Forming, and Long Half-Life Major Metabolite of Iclepertin

enthalten in: Pharmaceutical research | 2023

von Chan, T. | Byer-Alcorace, A. | Latli, B. | +8

5

Characterization of Divergent Metabolic Pathways in Elucidating an Unexpected, Slow-Forming, and Long Half-Life Major Metabolite of Iclepertin

enthalten in: Pharmaceutical research | 2023

von Chan, T. | Byer-Alcorace, A. | Latli, B. | +8

6

Characterization of Divergent Metabolic Pathways in Elucidating an Unexpected, Slow-Forming, and Long Half-Life Major Metabolite of Iclepertin

enthalten in: Pharmaceutical research | 2023

von Chan, T. | Byer-Alcorace, A. | Latli, B. | +8

7

Characterization of Divergent Metabolic Pathways in Elucidating an Unexpected, Slow-Forming, and Long Half-Life Major Metabolite of Iclepertin

enthalten in: Pharmaceutical research | 2023

von Chan, T. | Byer-Alcorace, A. | Latli, B. | +8

8

Correction to : The Absolute Bioavailability, Absorption, Distribution, Metabolism, and Excretion of BI 425809 Administered as an Oral Dose or an Oral Dose with an Intravenous Microtracer Dose of [14C]‑BI 425809 in Healthy Males

enthalten in: Clinical drug investigation | 2022

von Burkard, U. | Desch, M. | Shatillo, Y. | +6

ErratumFor: Clin Drug Investig. 2022 Jan;42(1):87-99. - PMID 34936055

9

Correction to: The Absolute Bioavailability, Absorption, Distribution, Metabolism, and Excretion of BI 425809 Administered as an Oral Dose or an Oral Dose with an Intravenous Microtracer Dose of [14C]‑BI 425809 in Healthy Males

enthalten in: Clinical drug investigation | 2022

von Burkard, U. | Desch, M. | Shatillo, Y. | +6

10

Correction to: The Absolute Bioavailability, Absorption, Distribution, Metabolism, and Excretion of BI 425809 Administered as an Oral Dose or an Oral Dose with an Intravenous Microtracer Dose of [14C]‑BI 425809 in Healthy Males

enthalten in: Clinical drug investigation | 2022

von Burkard, U. | Desch, M. | Shatillo, Y. | +6

1
2
3
4
5
6
7
Nächster »
[7]